Firehawk Rapamycin Target Eluting Coronary Stent

Rapamycin-target eluting coronary stent · Shanghai MicroPort Medical (Group) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Firehawk Rapamycin Target Eluting Coronary Stent, covering 2024-07-24 to 2024-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Firehawk Rapamycin Target Eluting Coronary Stent North American Trial [NA]